MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing Oct 28 • 5 min read Mind Medicine (MindMed) Inc. announced that it has filed a final short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec.
ATAI Life Sciences Announces Neuronasal Completes Pilot Study, Receives IND Clearance to Continue into Phase I Trials of mTBI Therapeutic Oct 27 • 4 min read ATAI Life Sciences announced that Neuronasal Inc. has completed its pilot study intended to show nose to brain delivery of N-acetylcysteine (NAC) in healthy volunteers.
Field Trip Health Ltd. : Continues Expansion With Psychedelic-Enhanced Therapy Center in Chicago Oct 26 • 7 min read Field Trip Health Ltd. announced the opening of their Chicago center.
Numinus First Canadian Public Company to Complete Legal Harvest of Psilocybe Mushrooms Oct 22 • 7 min read Numinus Wellness Inc. has harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s Licence.
Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease Oct 21 • 6 min read Pharmather Inc. announced it has filed an application with the U.S. FDA to receive Orphan Drug Designation for ketamine.